{"id":657829,"date":"2023-03-17T15:29:37","date_gmt":"2023-03-17T17:29:37","guid":{"rendered":"https:\/\/teknomers.com\/fr\/late-briefing-entreprises-et-marches-2-8\/"},"modified":"2023-03-17T15:29:39","modified_gmt":"2023-03-17T17:29:39","slug":"late-briefing-entreprises-et-marches-2-8","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/late-briefing-entreprises-et-marches-2-8\/","title":{"rendered":"LATE BRIEFING &#8211; Entreprises et March\u00e9s -2-"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div id=\"news-container\">\n<p>  Le constructeur automobile Ford Motor doit commander pr\u00e8s de 1,3 million de v\u00e9hicules Ford Fusion et Lincoln MKZ dans les ateliers pour remplacer un flexible de frein qui pourrait se briser. <\/p>\n<p>  Merck &#038; Cie <\/p>\n<p>  a subi un \u00e9chec avec un essai de drogue.  La soci\u00e9t\u00e9 a annonc\u00e9 que la th\u00e9rapie combin\u00e9e vibostolimab et Keytruda n&#8217;avait pas donn\u00e9 de meilleurs r\u00e9sultats que la chimioth\u00e9rapie dans une \u00e9tude de phase 2 chez des patients atteints d&#8217;un cancer du poumon non \u00e0 petites cellules m\u00e9tastatique.  L&#8217;\u00e9tude n&#8217;a pas non plus atteint son crit\u00e8re d&#8217;\u00e9valuation principal en termes de survie sans progression. <!-- sh_cad_2 --><\/p>\n<p>=== <\/p>\n<p>  Contactez l&#8217;auteur : maerkte.de@dowjones.com <\/p>\n<p>  DJG\/cln <\/p>\n<p>  (FIN) Fil de presse Dow Jones<\/p>\n<p>  17 mars 2023 13h21 HE (17h21 GMT)<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/late-briefing-unternehmen-und-maerkte-2-12270653\" rel=\"nofollow noopener\" target=\"_blank\">ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le constructeur automobile Ford Motor doit commander pr\u00e8s de 1,3 million de v\u00e9hicules Ford Fusion et Lincoln MKZ dans les ateliers pour remplacer un flexible de frein qui pourrait se briser. Merck &#038; Cie a subi un \u00e9chec avec un essai de drogue. La soci\u00e9t\u00e9 a annonc\u00e9 que la th\u00e9rapie combin\u00e9e vibostolimab et Keytruda n&#8217;avait [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":577397,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[11575,3244,11574,4417],"class_list":["post-657829","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-briefing","tag-entreprises","tag-late","tag-marches"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/657829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=657829"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/657829\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/577397"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=657829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=657829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=657829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}